Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab[4] Bortezomib,
Cyclophosphamide,
Daratumumab,
Dexamethasone		[5] D00287 ,
D00292 ,
D03150 ,
D07760 ,
D10777 (Name: Daratumumab)		[3] CD38,
NR3C1,
PSMB5 💬		[16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬[1] 28
2Daratumumab[1] Daratumumab[1] D10777 (Name: Daratumumab)[1] CD38 💬[7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬[5] 13, 28, 48, 49, 63
3Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20)[2] Daratumumab,
Hyaluronidase (human recombinant)		[1] D10777 (Name: Daratumumab)[1] CD38 💬[7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬[1] 28
4Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20)[1] Daratumumab[1] D10777 (Name: Daratumumab)[1] CD38 💬[7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬[1] 28
5Daratumumab Injection[1] Daratumumab[1] D10777 (Name: Daratumumab)[1] CD38 💬[7] Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬[3] 28, 49, 63